LYPLA1
Basic information
Region (hg38): 8:54046366-54102017
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LYPLA1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 10 | 12 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 10 | 2 | 1 |
Variants in LYPLA1
This is a list of pathogenic ClinVar variants found in the LYPLA1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-54051026-T-A | not specified | Uncertain significance (Jan 04, 2022) | ||
8-54051122-C-T | not specified | Uncertain significance (Mar 04, 2024) | ||
8-54051141-G-A | Likely benign (Jul 01, 2023) | |||
8-54051179-C-T | not specified | Likely benign (Jan 17, 2023) | ||
8-54052660-G-A | Benign (May 24, 2018) | |||
8-54052695-G-C | not specified | Uncertain significance (Dec 13, 2021) | ||
8-54055098-T-C | not specified | Uncertain significance (Oct 06, 2022) | ||
8-54055112-T-A | not specified | Uncertain significance (Nov 07, 2022) | ||
8-54065770-T-C | not specified | Uncertain significance (Jul 09, 2021) | ||
8-54100911-G-A | not specified | Uncertain significance (Feb 13, 2024) | ||
8-54101781-G-A | not specified | Uncertain significance (Sep 14, 2022) | ||
8-54101787-T-C | not specified | Uncertain significance (Jun 07, 2023) | ||
8-54101817-C-T | not specified | Uncertain significance (Aug 17, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LYPLA1 | protein_coding | protein_coding | ENST00000316963 | 9 | 55640 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000365 | 0.835 | 125725 | 0 | 22 | 125747 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.03 | 88 | 120 | 0.734 | 0.00000593 | 1482 |
Missense in Polyphen | 17 | 32.457 | 0.52378 | 405 | ||
Synonymous | -0.416 | 45 | 41.6 | 1.08 | 0.00000221 | 434 |
Loss of Function | 1.32 | 9 | 14.4 | 0.625 | 7.08e-7 | 171 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000319 | 0.000312 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000115 | 0.000114 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000655 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Hydrolyzes fatty acids from S-acylated cysteine residues in proteins such as trimeric G alpha proteins or HRAS. Has depalmitoylating activity toward KCNMA1. Has low lysophospholipase activity. {ECO:0000269|PubMed:20418879, ECO:0000269|PubMed:22399288}.;
- Pathway
- Glycerophospholipid metabolism - Homo sapiens (human);Choline metabolism in cancer - Homo sapiens (human);Phospholipid Biosynthesis;Metabolism of nitric oxide;eNOS activation;eNOS activation and regulation;Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.162
Intolerance Scores
- loftool
- 0.723
- rvis_EVS
- 0.39
- rvis_percentile_EVS
- 76.05
Haploinsufficiency Scores
- pHI
- 0.657
- hipred
- N
- hipred_score
- 0.379
- ghis
- 0.550
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.954
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lypla1
- Phenotype
Gene ontology
- Biological process
- protein depalmitoylation;fatty acid metabolic process;negative regulation of Golgi to plasma membrane protein transport;regulation of nitric-oxide synthase activity
- Cellular component
- cytoplasm;cytosol;extracellular exosome
- Molecular function
- lysophospholipase activity;palmitoyl-(protein) hydrolase activity;lipase activity;carboxylic ester hydrolase activity